BP000419-HCV-250: Recombinant HCV NS3 Genotype-2b, (1356-1459 a.a.)
Source: E. coli-derived.
Purity >95% by 10% PAGE.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.BP000419-HCV-209: Recombinant HCV NS3 Genotype-2c, (1192-1459 a.a.)
Source: E. coli-derived.
Purity >95% by 10% PAGE.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.BP000419-HCV-210: Recombinant HCV NS3 Genotype-2b, (1192-1459)
Source: E. coli-derived.
Purity >95% by 10% PAGE.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.BP000419-HCV-249: Recombinant HCV NS3 Genotype-1b, (1356-1459 a.a.)
Source: E. coli-derived.
Purity>95%, as determined by 10% PAGE (coomassie staining).
Applications: ELISA, WB, Flow-through.BP000419-HCV-248: Recombinant HCV NS3 Genotype-1a, (1356-1459 a.a.)
Source: E. coli-derived.
Purity>95%, as determined by 10% PAGE (coomassie staining).BP000419-HCV-247: Recombinant HCV NS3 Genotype-1b, (1192-1459 a.a.)
Source: E. coli-derived.
Purity>95%, as determined by 10% PAGE (coomassie staining).
Applications: ELISA, WB, Flow-through.BP000419-HCV-246: Recombinant HCV NS3 Genotype-1a, (1192-1459 a.a.)
Source: E. coli-derived.
Purity>95% by 10% PAGE.
Applications: ELISA, WB. />Source: E. coli-derived.
Purity>95%, as determined by 10% PAGE (coomassie staining).
Applications: ELISA, WB, Flow-through.BP000419-HCV-208: Recombinant HCV NS3 Genotype-1c, (1192-1459 a.a.)
Source: E. coli-derived.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000419-HCV-204: Recombinant HCV NS3 Genotype-1b
Source: E. coli-derived.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000418-HCV-238: Recombinant HCV Core Genotype-3b
Source: E. coli-derived.
Purity >95% by 10% PAGE.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Formulation: 25 mM Tris-Hcl pH 8, 0.2% Triton-X, 1.5 M urea and 50% glycerol.